Immunomedics vet Itri takes CMO post at Aadi

Aadi Bioscience Inc. (NASDAQ:AADI) hired Loretta Itri as CMO. Itri was previously CMO at Immunomedics. Inc, which was acquired by Gilead Sciences Inc. (NASDAQ:GILD). Aadi is developing cancer treatments by targeting the mTOR pathway.

Mersana Therapeutics Inc. (NASDAQ:MRSN) hired Mohan Bala as SVP, strategic product planning and program leadership. Bala was previously COO at Constellation Pharmaceuticals Inc. (NASDAQ:CNST). Mersana is developing antibody-drug conjugates for oncology. ...